TGR5-mediated bile acid sensing controls glucose homeostasis C Thomas, A Gioiello, L Noriega, A Strehle, J Oury, G Rizzo, ... Cell metabolism 10 (3), 167-177, 2009 | 1952 | 2009 |
Aryl hydrocarbon receptor control of a disease tolerance defence pathway A Bessede, M Gargaro, MT Pallotta, D Matino, G Servillo, C Brunacci, ... Nature 511 (7508), 184-190, 2014 | 697 | 2014 |
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors E Wahlberg, T Karlberg, E Kouznetsova, N Markova, A Macchiarulo, ... Nature biotechnology 30 (3), 283-288, 2012 | 556 | 2012 |
Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure− activity relationships, and molecular modeling studies H Sato, A Macchiarulo, C Thomas, A Gioiello, M Une, AF Hofmann, ... Journal of medicinal chemistry 51 (6), 1831-1841, 2008 | 348 | 2008 |
A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells G Mondanelli, R Bianchi, MT Pallotta, C Orabona, E Albini, A Iacono, ... Immunity 46 (2), 233-244, 2017 | 294 | 2017 |
Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity R Pellicciari, A Gioiello, A Macchiarulo, C Thomas, E Rosatelli, B Natalini, ... Journal of medicinal chemistry 52 (24), 7958-7961, 2009 | 274 | 2009 |
Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1 E Ayroldi, O Zollo, A Macchiarulo, B Di Marco, C Marchetti, C Riccardi Molecular and cellular biology, 2002 | 250 | 2002 |
Modeling of poly (ADP-ribose) polymerase (PARP) inhibitors. Docking of ligands and quantitative structure− activity relationship analysis G Costantino, A Macchiarulo, E Camaioni, R Pellicciari Journal of medicinal chemistry 44 (23), 3786-3794, 2001 | 164 | 2001 |
Glucocorticoid-induced leucine zipper (GILZ)/NF-κB interaction: role of GILZ homo-dimerization and C-terminal domain BD Marco, M Massetti, S Bruscoli, A Macchiarulo, RD Virgilio, E Velardi, ... Nucleic acids research 35 (2), 517-528, 2007 | 156 | 2007 |
1, 4-Benzothiazine and 1, 4-benzoxazine imidazole derivatives with antifungal activity: a docking study A Macchiarulo, G Costantino, D Fringuelli, A Vecchiarelli, F Schiaffella, ... Bioorganic & medicinal chemistry 10 (11), 3415-3423, 2002 | 153 | 2002 |
Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2, 3-dioxygenase (IDO), a novel target in cancer disease A Macchiarulo, E Camaioni, R Nuti, R Pellicciari Amino acids 37, 219-229, 2009 | 148 | 2009 |
Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23-and 6, 23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein … R Pellicciari, H Sato, A Gioiello, G Costantino, A Macchiarulo, ... Journal of medicinal chemistry 50 (18), 4265-4268, 2007 | 123 | 2007 |
Poly (ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure L Formentini, A Macchiarulo, G Cipriani, E Camaioni, E Rapizzi, ... Journal of Biological Chemistry 284 (26), 17668-17676, 2009 | 114 | 2009 |
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new … C Carta, S Moretti, L Passeri, F Barbi, N Avenia, A Cavaliere, M Monacelli, ... Clinical Endocrinology 64 (1), 105-109, 2006 | 108 | 2006 |
Indoleamine 2, 3‐dioxygenase 1 (IDO1): an up‐to‐date overview of an eclectic immunoregulatory enzyme MT Pallotta, S Rossini, C Suvieri, A Coletti, C Orabona, A Macchiarulo, ... The FEBS journal 289 (20), 6099-6118, 2022 | 103 | 2022 |
Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid‐induced leucine zipper? A perspective E Ayroldi, A Macchiarulo, C Riccardi The FASEB Journal 28 (12), 5055-5070, 2014 | 99 | 2014 |
Ligand selectivity and competition between enzymes in silico A Macchiarulo, I Nobeli, JM Thornton Nature biotechnology 22 (8), 1039-1045, 2004 | 97 | 2004 |
Role of TGR5 (GPBAR1) in liver disease V Keitel, D Häussinger Seminars in liver disease 38 (04), 333-339, 2018 | 90 | 2018 |
PARP inhibitors: polypharmacology versus selective inhibition T Ekblad, E Camaioni, H Schüler, A Macchiarulo The FEBS journal 280 (15), 3563-3575, 2013 | 90 | 2013 |
Synthesis, docking studies and anti-inflammatory activity of 4, 5, 6, 7-tetrahydro-2H-indazole derivatives O Rosati, M Curini, MC Marcotullio, A Macchiarulo, M Perfumi, L Mattioli, ... Bioorganic & medicinal chemistry 15 (10), 3463-3473, 2007 | 90 | 2007 |